Euro
USD
British Pound
NULL
Product Description
SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein | 21-825 | ProSci
Tested Application: E
Application: This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.
Tpredicted Molecular Weight: 225 amino acids (including His tag); 25506 Da
Physical State: Liquid
Buffer: 20 mM Hepes pH 7.5; 150 mM NaCl
Storage Condition: –80˚C. Avoid freeze-thaw cycles
Alternate Name: SARS-CoV-2 (COVID-19) Spike RBD Recombinnat Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein
Background: N/A
Shipping: Dry Ice
Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.
Source: HEK293 cells
Species: SARS-CoV-2 (COVID-19, 2019-nCoV) Spike RBD Protein
By Source: Human Cells
By Species: Other
Fusion Tag: C-terminal His tag
Sequence: sequence (aa 319 – 537), N501Y
C-terminal His tag
Bological Activity: not determined
Purity: >98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Indigo Agarose.
